SK

Sanjay Kumar Gupta

Active Director Director DIN 10058242
DIN 10058242 First appointment Feb 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2023
Shareholding value •••• Premium profile

About Sanjay Kumar Gupta

Data last updated:

Sanjay Kumar Gupta is a Director at Arshaderm Health Care Private Limited (since 2023). Arshaderm Health Care Private Limited reported revenue of ₹25.1 Lakh (FY 2025).

DIN 10058242
Primary Designation Director
First Appointment 28 Feb 2023
Oldest Company Age 3 yrs
Largest company Arshaderm Health Care Private Limited · ₹25.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Feb 20232023₹25.1 Lakh (FY 2025)Active

Board colleagues of Sanjay Kumar Gupta

NameDINCompanyDesignation
Aayush Mittal10058241Arshaderm Health Care Private LimitedDirector

Directorship timeline

Open interactive timeline →
Arshaderm Health Care Private Limited
Premium access

Shareholding and investment profile for Sanjay Kumar Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Kumar Gupta

Sanjay Kumar Gupta currently holds 1 directorship: Arshaderm Health Care Private Limited (Director, since 28 Feb 2023, revenue ₹25.1 Lakh (FY 2025)).

Sanjay Kumar Gupta was first appointed on 28 Feb 2023 as Director at Arshaderm Health Care Private Limited.

The current boards of Sanjay Kumar Gupta's companies include Aayush Mittal (Arshaderm Health Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available